Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
04/14/2004 | CN1145488C Sustained-release microgranules containing diltiazem as active principle |
04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
04/14/2004 | CN1145484C Extended release tiagabine formulations with reduced side effects |
04/14/2004 | CN1145479C Pharmaceutical Preparation |
04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
04/14/2004 | CN1145414C Method for control of infestations of honeybee colonies |
04/13/2004 | US6721595 Percutaneous absorption promoters for electroporation |
04/13/2004 | US6720350 Reducing diminution in vessel lumen area with a therapeutic shunt having a cytoskeletal inhibitor to reduce stenosis or restenosis; taxols, cytochalasins |
04/13/2004 | US6720306 Drug delivery, antitumor agents |
04/13/2004 | US6720305 Ramoplanin (inn) is a known member of the cyclic peptide antibiotics more precisely known as glycolipodepsipeptides |
04/13/2004 | US6720304 Conjugate comprising a folic acid antagonist and a carrier |
04/13/2004 | US6720302 Method for preparing a γ-unsaturated β-lactone and use thereof as an aromatic and flavouring ingredient |
04/13/2004 | US6720011 Injectable composition for cancer treatment |
04/13/2004 | US6720002 Solubility and storage stability while maintaining bioavailability of drug |
04/13/2004 | US6719996 Galenic composition for low bioavailability medicaments |
04/13/2004 | US6719995 Flexible polybutene strips for preventing gingivitis/whitening of teeth |
04/13/2004 | US6719992 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
04/13/2004 | US6719990 Non-aqueous injectable formulations for extended release of somatotropin |
04/13/2004 | US6719989 Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
04/13/2004 | US6719987 Sustained release of metal microbiocides |
04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
04/13/2004 | US6719974 Heat shock protein-based vaccines and immunotherapies |
04/13/2004 | US6719963 Liquid oral compositions comprising a calcium compound and an acidulant |
04/13/2004 | US6719839 Stable dispersion such as of a porphyrin pigment, carmine, curcumin or a carotenoid in the form of bodies of given size, dispersed without use of a suface active substance in an an aqueous phase including a hydrocolloid; food coloring |
04/13/2004 | CA2374877C Pharmaceutical formulations and methods comprising intranasal morphine |
04/13/2004 | CA2348090C Oral pulsed dose drug delivery system |
04/13/2004 | CA2090953C High pullulan content product, and its preparation and uses |
04/08/2004 | WO2004029095A2 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
04/08/2004 | WO2004029073A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
04/08/2004 | WO2004029018A1 Glycerol derivative |
04/08/2004 | WO2004028589A2 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
04/08/2004 | WO2004028569A1 Polymer compositions for administration to animals |
04/08/2004 | WO2004028568A1 Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol) |
04/08/2004 | WO2004028567A1 Drug absorbability improving agents |
04/08/2004 | WO2004028557A1 Stabilized protein compositions |
04/08/2004 | WO2004028556A1 Sustained release preparation for treating coronary stenosis or obstruction |
04/08/2004 | WO2004028551A1 Novel agents that modulate eph receptor activity |
04/08/2004 | WO2004028536A1 Method for topical treatment of eye disease and composition and device for said treatment |
04/08/2004 | WO2004028523A1 Particulate product comprising pantethine |
04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
04/08/2004 | WO2004028519A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
04/08/2004 | WO2004028515A1 Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
04/08/2004 | WO2004028501A1 Thickener compositions comprising sclerotium gum and a copolymer |
04/08/2004 | WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
04/08/2004 | WO2004028457A2 PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY |
04/08/2004 | WO2004028274A1 Enzyme preparation and process for producing food using the same |
04/08/2004 | WO2004028272A2 Injectable growth promoting and anthelmintic composition |
04/08/2004 | WO2004018468A3 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
04/08/2004 | WO2004012722A3 Bicifadine formulation |
04/08/2004 | WO2004010984A3 Microcapsules with modified release of active principles with low solubility for oral delivery |
04/08/2004 | WO2004009136A3 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
04/08/2004 | WO2004004687A3 Liposomal vaccine |
04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
04/08/2004 | WO2003106619A3 Multifunctional polypeptides |
04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
04/08/2004 | WO2003105765A3 Phospholipid micelles in liposomes as solubilizers for water-insoluble compounds |
04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
04/08/2004 | WO2003101384A3 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
04/08/2004 | WO2003094617A3 Use of vegf for treating bone defects |
04/08/2004 | WO2003093469A3 Methods for delivering nucleic acid molecules into cells and assessment thereof |
04/08/2004 | WO2003092633A3 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
04/08/2004 | WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_ |
04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
04/08/2004 | WO2003080023A3 Fast dissolving dosage forms having reduced friability |
04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
04/08/2004 | WO2003072083A3 Melt extrusion consisting of salts of active ingredients |
04/08/2004 | WO2003061728B1 Oral administration of interferon-tau |
04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
04/08/2004 | WO2003009881A3 Novel targeted delivery system for bioactive agents |
04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
04/08/2004 | WO2002087500A9 Viral enzyme activated prototoxophores and use of same to treat viral infections |
04/08/2004 | WO2002056918B1 Method of enhancing delivery of a therapeutic nucleic acid |
04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
04/08/2004 | US20040068141 Process for the synthesis of trifluorophenylacetic acids |
04/08/2004 | US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions |
04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
04/08/2004 | US20040068009 Systemic formulations containing beta-carotene and derivatives thereof |
04/08/2004 | US20040067993 Famotidine injections |
04/08/2004 | US20040067952 Method and composition for treatment of cancer |
04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
04/08/2004 | US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
04/08/2004 | US20040067926 Sustained-release suspension of ceftiofur hydrochloride |
04/08/2004 | US20040067925 Multilayer tablet containing amyoxycillin, or sodium salt thereof |
04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
04/08/2004 | US20040067909 Eye drops |
04/08/2004 | US20040067907 Process for delivery of polynucleotides to the prostate |
04/08/2004 | US20040067895 Molluscs extract; anticancer agents |
04/08/2004 | US20040067894 Preparation having antioxidant properties |
04/08/2004 | US20040067875 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |